Alkermes Plc (ALKS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALKS | MRNA | BMY | AMGN | GILD |
| Company | Alkermes Plc | Moderna Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 24.39 | 107.43 | 47.39 | 273.45 | 67.47 |
| High | 24.60 | 108.23 | 47.50 | 274.35 | 67.90 |
| Low | 23.89 | 103.52 | 44.61 | 267.24 | 65.32 |
| Last | 24.38 | 105.11 | 44.69 | 269.50 | 65.72 |
| Change | -0.27 | -3.74 | -4.17 | -3.51 | -1.36 |
| % Change | -1.10% | -3.44% | -8.53% | -1.29% | -2.03% |
| Volume | 451,165 | 1,522,519 | 25,100,772 | 635,588 | 4,865,416 |
| 20-Day Average Volume | 1,821,577 | 3,071,012 | 11,785,491 | 2,089,843 | 6,323,123 |
| Previous Close | 24.65 | 108.85 | 48.86 | 273.01 | 67.08 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 25.21 | 104.94 | 49.94 | 270.64 | 68.69 |
| 20-Day Raw Stochastic | 21.32% | 41.87% | 0.41% | 26.56% | 1.05% |
| 20-Day Relative Strength | 38.57% | 51.54% | 28.33% | 43.71% | 28.64% |
| Weighted Alpha | -18.74 | -12.87 | -34.73 | +8.39 | -23.50 |
| Today's Opinion | 88% Sell | 88% Buy | 88% Sell | 72% Sell | 100% Sell |
| Previous Opinion | 72% Sell | 88% Buy | 88% Sell | 40% Sell | 100% Sell |
| Last Month's Opinion | 8% Sell | 72% Buy | 8% Sell | 24% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.48% since 04/18/24 | +2.85% since 04/18/24 | -7.43% since 04/18/24 | +2.03% since 04/18/24 | -1.13% since 04/18/24 |
| Low | 23.48 on 04/19/24 | 99.30 on 04/22/24 | 44.67 on 04/25/24 | 260.68 on 04/19/24 | 65.32 on 04/25/24 |
| High | 24.81 on 04/24/24 | 111.29 on 04/24/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.78 on 04/25/24 |
| 1-Month | |||||
| %Chg | -10.84% since 03/25/24 | -4.96% since 03/25/24 | -14.43% since 03/25/24 | -4.53% since 03/25/24 | -9.88% since 03/25/24 |
| Low | 23.48 on 04/19/24 | 97.00 on 04/03/24 | 44.67 on 04/25/24 | 260.68 on 04/19/24 | 65.32 on 04/25/24 |
| High | 27.56 on 04/09/24 | 115.89 on 04/09/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 |
| 3-Month | |||||
| %Chg | -13.10% since 01/25/24 | +2.04% since 01/25/24 | -9.88% since 01/25/24 | -13.59% since 01/25/24 | -18.47% since 01/25/24 |
| Low | 23.48 on 04/19/24 | 84.06 on 02/13/24 | 44.67 on 04/25/24 | 260.68 on 04/19/24 | 65.32 on 04/25/24 |
| High | 32.88 on 02/16/24 | 115.89 on 04/09/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 |
| 6-Month | |||||
| %Chg | +3.84% since 10/25/23 | +36.67% since 10/25/23 | -21.02% since 10/25/23 | -1.50% since 10/25/23 | -16.56% since 10/25/23 |
| Low | 22.06 on 11/16/23 | 62.55 on 11/02/23 | 44.67 on 04/25/24 | 249.70 on 10/31/23 | 65.32 on 04/25/24 |
| High | 32.88 on 02/16/24 | 115.97 on 01/08/24 | 55.29 on 10/26/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,170,386 | 41,676,488 | 99,027,448 | 146,436,016 | 83,519,768 |
| Shares Outstanding, K | 169,184 | 382,880 | 2,026,759 | 536,376 | 1,245,077 |
| Annual Sales | 1,663,410,000 | 6,848,000,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | 355,760,000 | -4,714,000,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 377,480,000 | 2,811,000,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 |
| Last Quarter Net Income | 112,780,000 | 217,000,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 |
| 60-Month Beta | 0.55 | 1.62 | 0.39 | 0.58 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.48 on 02/15/24 | 0.55 on 02/22/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 |
| Latest Earnings Date | 05/01/24 | 05/02/24 | 04/25/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | N/A | 04/04/24 | 05/16/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 21.66 | 0.00 | 6.53 | 14.67 | 9.97 |